How should I structure my weekly training volume when running Testabol Depot?

Begin at 12–16 working sets per muscle group per week during the first four weeks while testosterone builds toward steady state. Once serum levels stabilise — typically by week four — progressive overload supports 18–22 sets per week. Matching volume to hormonal availability prevents connective tissue overreach early in the cycle and maximises strength adaptation during peak androgen weeks.

When is the best time to programme a deload week inside a Testosterone Cypionate cycle?

A planned deload at weeks eight to nine — reducing working sets by roughly 40% while holding load — allows tendons and ligaments to catch up with muscle growth accelerated by sustained androgen receptor signalling. Because Testosterone Cypionate maintains anabolic conditions through the reduced-volume week, muscle tissue is protected from the catabolic dip that deloads can cause in natural athletes.

How does the accumulation phase of a cycle affect exercise selection and rep ranges?

During the accumulation phase (weeks one through four), compound movements at moderate rep ranges (6–12) build the mechanical base while testosterone rises. As steady state is reached, adding higher-intensity strength work (3–6 reps) capitalises on the increased androgen-driven neuromuscular efficiency. This two-phase exercise selection strategy extracts more total adaptation than running a single rep range throughout.

Why does Testabol Depot's 200mg/ml concentration make dose adjustments easier for training-phase transitions?

At 200mg/ml, each 0.1ml corresponds to exactly 20mg of active testosterone — finer granularity than higher-concentration vials. This allows athletes to step weekly dose down by 40mg increments when transitioning from intensification to a deload or taper phase, matching hormonal reduction to reduced training stimulus without overshooting into sub-physiological territory.

How should Testabol Depot vials be stored after first use, and does this affect dosing accuracy?

After first puncture, store the vial at room temperature (15–25°C) away from direct light; refrigeration is not required but is acceptable if the oil is warmed briefly before drawing. Proper storage preserves the 200mg/ml concentration across all subsequent draws — a consideration that directly affects dose accuracy across the 12–16 injections a single 10ml vial covers in a standard weekly protocol. (2) angle_used

Recomp Optimizer

British Dragon

Testabol Depot 200mg/ml 10ml Vial by British Dragon

Name: Testabol Depot
Brand: British Dragon
SKU: INJ-TCYP-BRD-200-028
Price: 28.00 EUR
Availability: InStock

Testabol Depot is a 200mg/ml injectable Testosterone Cypionate solution by British Dragon, supplied in a 10ml multi-dose vial and specifically suited to athletes who structure training blocks around a running anabolic cycle. The 200mg/ml concentration — the lowest in this product group — delivers precise, graduated dose increments that align naturally with periodised training phases from accumulation to intensification. Quality assurance is applied at two stages: upstream API documentation review and finished-product HPLC potency release testing, each batch required to match the 200mg/ml label claim before dispatch.

€28.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Supports progressive overload across full 12–16 week training macrocycles without mid-cycle resupply
200mg/ml concentration enables 20mg-increment dose steps aligned to training phase transitions
Sustained depot release maintains anabolic conditions through planned deload weeks
HPLC-confirmed potency removes concentration uncertainty that could skew training-phase hormonal targets
Single 10ml vial eliminates procurement gaps that disrupt structured training continuity
Predictable single-ester pharmacokinetics simplify recovery and PCT scheduling around training calendar

Phase	dosage	Note
Accumulation (Weeks 1–4)	200–300mg/week	Build mechanical base while testosterone rises toward steady state; 12–16 sets/muscle/week
Intensification (Weeks 5–10)	300–500mg/week	Steady-state androgens support 18–22 sets/muscle/week and progressive overload in 3–12 rep range
Deload (Weeks 8–9, within intensification)	Maintain current dose	Reduce training volume ~40%; cypionate sustains anabolism through reduced mechanical stimulus
Taper / Transition (Weeks 11–14)	200mg/week stepping down	Reduce dose in 40mg increments alongside declining training intensity to prepare HPG axis for PCT

Key takeaways

Align training volume with Testosterone Cypionate's accumulation curve each week.
Programme a deload at weeks eight to nine to protect connective tissue.
Leverage 200mg/ml granularity to taper dose alongside training intensity.
Intensify to 18–22 sets per muscle once steady-state androgens are confirmed.
Cover a full macrocycle from a single HPLC-verified 10ml vial.

Testosterone Cypionate as a Training-Phase Anchor

Testabol Depot by British Dragon is a depot-release androgen preparation in which Testosterone Cypionate at 200mg/ml functions as a programmable hormonal base that athletes align with distinct training blocks rather than running as an undifferentiated background compound. Testosterone Cypionate supports nitrogen retention across variable training intensities, meaning its anabolic contribution shifts in proportion to the mechanical stimulus applied each week. Compared to shorter-ester preparations, the cypionate depot's multi-week accumulation curve rewards pre-planned training structures where volume and load progress predictably rather than fluctuating week to week.

Matching Training Volume to Cycle Phase

The training plan on cycle should mirror the hormonal trajectory of the compound itself. During the first three to four weeks — before Testosterone Cypionate reaches pharmacokinetic steady state — moderate training volume (roughly 12–16 working sets per muscle group per week, consistent with hypertrophy load recommendations from the NSCA Position Statement) builds the mechanical foundation without outrunning androgen availability. Once circulating testosterone stabilises at weeks four through ten, progressive overload capacity expands: trained athletes can sustain 18–22 sets per muscle group per week as recovery rate accelerates alongside elevated androgen receptor signalling in skeletal muscle. British Dragon's Testabol Depot delivers a consistent hormonal environment during this intensification window because HPLC-confirmed potency at 200mg/ml eliminates batch-to-batch concentration drift that would otherwise introduce unexpected hormonal variance mid-programme.

Deload and Transition Planning

A planned deload week at weeks eight to nine — cutting working sets by approximately 40% while maintaining load — permits connective tissue adaptation to catch up with accelerated muscle hypertrophy. Testosterone Cypionate sustains anabolic conditions through this reduced-volume week, preventing the catabolic regression that a deload can trigger in unassisted athletes. The final two to three weeks of the cycle should taper training intensity progressively rather than abruptly, bridging smoothly into the post-cycle recovery period. Testabol Depot's 10ml vial format covers a full twelve-to-sixteen-week training macrocycle from a single container, removing mid-programme resupply interruptions that can disrupt training continuity.

Usage

Map your training macrocycle (accumulation → intensification → deload → taper) before the first injection so dose adjustments can be scheduled against training weeks rather than decided reactively.
Draw from the Testabol Depot vial using an 18–21g needle for aspiration; warm the vial to 37°C in a water bath for 60 seconds to reduce oil viscosity and ensure complete draw at 200mg/ml.
Inject into the ventrogluteal or vastus lateralis on a lower-body training day during accumulation weeks — pairing the injection day with significant mechanical stimulus amplifies acute anabolic signalling.
Split the weekly volume into two equal injections (e.g. Monday and Thursday) to reduce intra-week trough depth, which is particularly relevant when training frequency increases during intensification.
Log each injection date, volume, and the training block in progress; cross-reference with weekly bodyweight and performance metrics to confirm the hormonal and mechanical inputs are producing the expected adaptation.
Begin reducing injection volume in week eleven in line with your taper block, and schedule a blood panel at week fourteen to confirm testosterone clearance trajectory before initiating post-cycle therapy.

Warnings

contraindications: Not for use in individuals with androgen-sensitive malignancy, active thromboembolism, severe hepatic impairment, or uncontrolled polycythaemia. Not approved for female use in competitive or recreational bodybuilding contexts due to virilisation risk.

side_effects: Elevated haematocrit, acne, androgenic alopecia, gynecomastia from aromatisation, injection-site induration. Erythrocytosis risk increases with higher weekly doses sustained through long training cycles; monitor haematocrit at 6-week intervals.

monitoring: Obtain baseline bloodwork (total testosterone, LH, FSH, haematocrit, lipid panel, PSA in men over 40) before cycle start. Repeat at mid-cycle (week six to eight) and at cycle end. Adjust aromatase inhibitor based on confirmed estradiol data, not presumptively.

pct: Allow adequate clearance time after the final injection before initiating SERM-based PCT. Standard post-cycle therapy employs Clomiphene or Tamoxifen across a four-to-six-week recovery window. Do not begin PCT while residual cypionate depot is still suppressing LH.

Frequently asked questions

How should I structure my weekly training volume when running Testabol Depot?: Begin at 12–16 working sets per muscle group per week during the first four weeks while testosterone builds toward steady state. Once serum levels stabilise — typically by week four — progressive overload supports 18–22 sets per week. Matching volume to hormonal availability prevents connective tissue overreach early in the cycle and maximises strength adaptation during peak androgen weeks.
When is the best time to programme a deload week inside a Testosterone Cypionate cycle?: A planned deload at weeks eight to nine — reducing working sets by roughly 40% while holding load — allows tendons and ligaments to catch up with muscle growth accelerated by sustained androgen receptor signalling. Because Testosterone Cypionate maintains anabolic conditions through the reduced-volume week, muscle tissue is protected from the catabolic dip that deloads can cause in natural athletes.
How does the accumulation phase of a cycle affect exercise selection and rep ranges?: During the accumulation phase (weeks one through four), compound movements at moderate rep ranges (6–12) build the mechanical base while testosterone rises. As steady state is reached, adding higher-intensity strength work (3–6 reps) capitalises on the increased androgen-driven neuromuscular efficiency. This two-phase exercise selection strategy extracts more total adaptation than running a single rep range throughout.
Why does Testabol Depot's 200mg/ml concentration make dose adjustments easier for training-phase transitions?: At 200mg/ml, each 0.1ml corresponds to exactly 20mg of active testosterone — finer granularity than higher-concentration vials. This allows athletes to step weekly dose down by 40mg increments when transitioning from intensification to a deload or taper phase, matching hormonal reduction to reduced training stimulus without overshooting into sub-physiological territory.
How should Testabol Depot vials be stored after first use, and does this affect dosing accuracy?: After first puncture, store the vial at room temperature (15–25°C) away from direct light; refrigeration is not required but is acceptable if the oil is warmed briefly before drawing. Proper storage preserves the 200mg/ml concentration across all subsequent draws — a consideration that directly affects dose accuracy across the 12–16 injections a single 10ml vial covers in a standard weekly protocol. (2) angle_used

Manufacturer

British Dragon's distribution and logistics framework for Testabol Depot is built around preserving product integrity from fill-line to end user — a priority that shaped both the 10ml multi-dose vial format and the labelling specification. Each vial exits the manufacturing suite with a tamper-evident closure and a batch-coded label traceable to the specific HPLC release record for that production run; this linkage between physical unit and analytical record allows downstream verification of the 200mg/ml potency claim at any point in the distribution chain. Cold-chain sensitivity is low for oil-based testosterone preparations at this concentration, but British Dragon specifies controlled ambient storage (15–25°C) throughout distribution to prevent ester degradation over the transit windows typical of international fulfilment. Secondary packaging is configured to protect the glass vial against mechanical stress during courier handling, reflecting the brand's recognition that injectable sterility assurance begins at the factory seal and must be maintained through the final kilometre of logistics.

Product details

Brand	British Dragon
Active ingredient	testosterone cypionate
Also known as	Testosterone Cypionate, Test C, Depo-Testosteronee, Testabol Depot, British Dragon Testosterone Cypionate
Strength	200 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TCYP-BRD-200-028

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Cipandrol 200mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Cipandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Cipandrol is a pharmaceutical-grade injectable testosterone preparation built around Testosterone Cypionate at 200 mg/ml — a compound whose origins trace back to American clinical research of the 1950s, when chemists at Upjohn first attached the cypionate ester to extend testosterone's therapeutic window. Presented in individual glass ampoules (10 × 1 ml), each unit delivers a precise, single-use dose free from the cross-contamination risk inherent in repeatedly punctured multi-dose vials. Sterility and potency are verified through independent HPLC quantification and LAL endotoxin screening conducted at Balkan Pharmaceuticals' GMP-certified Chișinău facility.

€38.00

High Concentration

Cypo-Testosterone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

Cypo-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable androgen — Testosterone Cypionate at 200 mg per millilitre in a 10 ml multi-dose vial — engineered specifically to slot into structured, periodised cycle frameworks. At this concentration, each 1 ml draw delivers a precise 200 mg dose, giving cycle planners clean arithmetic when calculating weekly volume across bulking, maintenance, or recomposition phases. Quality assurance is enforced at every stage: HPLC-verified potency, LAL endotoxin testing, and GMP-certified filling conditions underpin every vial released under the Beligas label.

€38.00

Testacyp-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Testacyp-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Testacyp-250 is an oil-based injectable testosterone ester in which Testosterone Cypionate at 250 mg/ml is engineered around its extended pharmacokinetic profile — delivering a clinically measurable half-life of approximately 8 days that sustains androgen receptor saturation between injections. Each 1 ml single-dose ampoule provides precise, pre-measured delivery in a hermetically sealed format that eliminates multi-use contamination risk. Quality assurance at BM Pharmaceuticals is built into every production stage: HPLC potency verification, LAL endotoxin screening, and GMP-certified fill-finish operations underpin every released batch.

€38.00

Brand Quality

CypioTrex 350mg/ml 10ml Vial by Concentrex Labs

CypioTrex is a high-concentration testosterone cypionate injectable — 350 mg/ml in a 10 ml multi-dose vial — engineered specifically for athletes running structured cruise-and-blast protocols that require distinct, clearly separated androgenic phases. At 350 mg/ml, each millilitre delivers 75% more active compound than standard 200 mg/ml preparations, reducing injection volume while maintaining full dosing flexibility across both the high-output blast window and the lower-dose cruise interval. Every batch is released only after passing in-house HPLC potency verification and LAL endotoxin screening, with GMP-aligned documentation supporting each production stage.

€38.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00